Article info
Chronic obstructive pulmonary disease
Original article
Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study
- Correspondence to Dr James R Brown, Computational Biology, Target Sciences, Research and Development (R&D), GlaxoSmithKline (GSK), Collegeville, PA 19426, USA; james.r.brown{at}gsk.com
Citation
Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study
Publication history
- Received July 7, 2017
- Revised November 2, 2017
- Accepted November 27, 2017
- First published December 21, 2017.
Online issue publication
March 19, 2018
Article Versions
- Previous version (21 December 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.